Astal Laboratories share news, announcements and annual reports
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
ASTAL LABORATORIES LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1994
Last close ₹61.70down ₹1.37 (2.17%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹63.07.
30 Oct: open ₹63.95, high ₹64.00, low ₹60.10
52-week range of traded prices to 30 Oct 2026
₹60.10Low, 30 Oct 2026₹100.00High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹270 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 0.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 12,192
Astal Laboratories board meetings
135 filed, newest first. Page 2 of 3.
Nov 2023
Oct 2023
9 Oct · Board meeting
Meeting on 13 Oct 2023
Aug 2023
11 Aug · Board meeting
Meeting on 18 Aug 2023: preferential issue of shares, annual general meeting and increase in authorised capital
Jul 2023
10 Jul · Board meeting
Meeting on 15 Jul 2023: quarterly results
Jun 2023
May 2023
23 May · Board meeting
Meeting on 27 May 2023: audited results
Apr 2023
19 Apr · Board meeting
Meeting on 19 Apr 2023
Feb 2023
7 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Jan 2023
Dec 2022
20 Dec · Board meeting
Meeting on 23 Dec 2022
Nov 2022
14 Nov · Board meeting
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
18 Oct · Board meeting
14 Oct · Board meeting
Meeting on 18 Oct 2022
Sep 2022
5 Sep · Board meeting
Meeting on 8 Sep 2022: annual general meeting
Aug 2022
5 Aug · Board meeting
Meeting on 11 Aug 2022: quarterly results
May 2022
30 May · Board meeting
23 May · Board meeting
Meeting on 30 May 2022: quarterly results
Feb 2022
1 Feb · Board meeting
Meeting on 8 Feb 2022: quarterly results
Nov 2021
1 Nov · Board meeting
Meeting on 10 Nov 2021: quarterly results
Oct 2021
Sep 2021
1 Sep · Board meeting
Aug 2021
24 Aug · Board meeting
Meeting on 1 Sep 2021: annual general meeting12 Aug · Board meeting
2 Aug · Board meeting
Meeting on 12 Aug 2021: quarterly results
Jun 2021
30 Jun · Board meeting
22 Jun · Board meeting
Meeting on 30 Jun 2021: quarterly results and audited results
Mar 2021
2 Mar · Board meeting